NCT00026494View on ClinicalTrials.gov

Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Metastatic Cancer
Interventions
DRUG

temozolomide

DRUG

vinorelbine tartrate

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

60611-3013

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Northwestern Memorial Hospital

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00026494 - Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases | Biotech Hunter | Biotech Hunter